BG100248A - Инхибитори на скваленсинтетаза - Google Patents
Инхибитори на скваленсинтетазаInfo
- Publication number
- BG100248A BG100248A BG100248A BG10024895A BG100248A BG 100248 A BG100248 A BG 100248A BG 100248 A BG100248 A BG 100248A BG 10024895 A BG10024895 A BG 10024895A BG 100248 A BG100248 A BG 100248A
- Authority
- BG
- Bulgaria
- Prior art keywords
- squalensenteza
- inhibitors
- hypochlesterolemic
- benzoxazepinons
- benzasepinons
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36271394A | 1994-12-23 | 1994-12-23 | |
| PCT/IB1995/000424 WO1996020184A1 (fr) | 1994-12-23 | 1995-06-02 | Naphtyl-benzoxazepines ou benzothiazepines inhibitant la squalene synthetase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG100248A true BG100248A (bg) | 1996-07-31 |
Family
ID=23427229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100248A BG100248A (bg) | 1994-12-23 | 1995-12-21 | Инхибитори на скваленсинтетаза |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5770594A (fr) |
| JP (1) | JPH10500702A (fr) |
| KR (1) | KR960022510A (fr) |
| CN (1) | CN1133287A (fr) |
| AU (1) | AU4067795A (fr) |
| BG (1) | BG100248A (fr) |
| BR (1) | BR9505995A (fr) |
| CA (1) | CA2207772A1 (fr) |
| CZ (1) | CZ344795A3 (fr) |
| FI (1) | FI972696A0 (fr) |
| GT (1) | GT199500058A (fr) |
| HU (1) | HUT74672A (fr) |
| IL (1) | IL116399A0 (fr) |
| IS (1) | IS4312A (fr) |
| LV (1) | LV11325B (fr) |
| MA (1) | MA23746A1 (fr) |
| MX (1) | MX9704683A (fr) |
| NO (1) | NO955288L (fr) |
| OA (1) | OA10204A (fr) |
| PE (1) | PE60096A1 (fr) |
| PL (1) | PL311997A1 (fr) |
| SI (1) | SI9500393A (fr) |
| SK (1) | SK158795A3 (fr) |
| TN (1) | TNSN95133A1 (fr) |
| TR (1) | TR199501644A2 (fr) |
| WO (1) | WO1996020184A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| AU2401697A (en) * | 1996-06-20 | 1998-01-07 | Pfizer Inc. | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
| DE19716120A1 (de) * | 1997-04-17 | 1998-10-22 | Europ Lab Molekularbiolog | Verwendung von cholesterinsenkenden Mitteln |
| US8679534B2 (en) * | 1997-12-12 | 2014-03-25 | Andrx Labs, Llc | HMG-CoA reductase inhibitor extended release formulation |
| US6403576B1 (en) * | 1998-08-24 | 2002-06-11 | The United States Of America As Represented By The Secretary Of The Navy | Antifungal and antiparasitic compounds |
| US20020054871A1 (en) * | 1999-04-12 | 2002-05-09 | Yadong Huang | Methods and compositions for use in the treatment of hyperlipidemia |
| US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
| CA2389973A1 (fr) * | 1999-11-04 | 2001-05-10 | Andrx Corporation | Methode de traitement de troubles lies au precurseur beta-amyloide |
| ATE434615T1 (de) | 2000-11-21 | 2009-07-15 | Janssen Pharmaceutica Nv | Farnesyltransferase hemmende benzoheterocyclische derivate |
| WO2008121602A1 (fr) * | 2007-03-29 | 2008-10-09 | Smithkline Beecham Corporation | Composés chimiques |
| GB0803747D0 (en) * | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0567026B1 (fr) * | 1992-04-20 | 2003-03-26 | Takeda Chemical Industries, Ltd. | Dérivés de 4,1-benzoxazepine comme inhibiteurs de la synthétase du squalène et leur application dans le traitement d'hypercholesteremie et comme fongicides |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| US5807834A (en) * | 1994-09-20 | 1998-09-15 | Pfizer Inc. | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
-
1995
- 1995-06-02 WO PCT/IB1995/000424 patent/WO1996020184A1/fr not_active Ceased
- 1995-06-02 US US08/860,155 patent/US5770594A/en not_active Expired - Fee Related
- 1995-06-02 FI FI972696A patent/FI972696A0/fi not_active Application Discontinuation
- 1995-06-02 SK SK1587-95A patent/SK158795A3/sk unknown
- 1995-06-02 JP JP8520314A patent/JPH10500702A/ja active Pending
- 1995-06-02 CA CA002207772A patent/CA2207772A1/fr not_active Abandoned
- 1995-06-02 MX MX9704683A patent/MX9704683A/es not_active IP Right Cessation
- 1995-06-02 BR BR9505995A patent/BR9505995A/pt not_active Application Discontinuation
- 1995-12-13 GT GT199500058A patent/GT199500058A/es unknown
- 1995-12-14 IL IL11639995A patent/IL116399A0/xx unknown
- 1995-12-18 PE PE1995287390A patent/PE60096A1/es not_active Application Discontinuation
- 1995-12-18 MA MA24097A patent/MA23746A1/fr unknown
- 1995-12-19 IS IS4312A patent/IS4312A/is unknown
- 1995-12-21 PL PL95311997A patent/PL311997A1/xx unknown
- 1995-12-21 BG BG100248A patent/BG100248A/xx unknown
- 1995-12-21 LV LVP-95-379A patent/LV11325B/en unknown
- 1995-12-21 TN TNTNSN95133A patent/TNSN95133A1/fr unknown
- 1995-12-22 HU HU9503783A patent/HUT74672A/hu unknown
- 1995-12-22 CN CN95120143A patent/CN1133287A/zh active Pending
- 1995-12-22 KR KR1019950054933A patent/KR960022510A/ko not_active Ceased
- 1995-12-22 OA OA60759A patent/OA10204A/en unknown
- 1995-12-22 SI SI9500393A patent/SI9500393A/sl unknown
- 1995-12-22 AU AU40677/95A patent/AU4067795A/en not_active Abandoned
- 1995-12-22 TR TR95/01644A patent/TR199501644A2/xx unknown
- 1995-12-22 NO NO955288A patent/NO955288L/no unknown
- 1995-12-22 CZ CZ953447A patent/CZ344795A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE60096A1 (es) | 1996-12-28 |
| CA2207772A1 (fr) | 1996-07-04 |
| US5770594A (en) | 1998-06-23 |
| FI972696L (fi) | 1997-06-23 |
| JPH10500702A (ja) | 1998-01-20 |
| SI9500393A (en) | 1997-04-30 |
| LV11325A (lv) | 1996-06-20 |
| KR960022510A (ko) | 1996-07-18 |
| TR199501644A2 (tr) | 1996-11-21 |
| WO1996020184A1 (fr) | 1996-07-04 |
| TNSN95133A1 (fr) | 1996-02-06 |
| SK158795A3 (en) | 1997-01-08 |
| CN1133287A (zh) | 1996-10-16 |
| IS4312A (is) | 1996-06-24 |
| NO955288L (no) | 1996-06-24 |
| NO955288D0 (no) | 1995-12-22 |
| OA10204A (en) | 1996-12-18 |
| GT199500058A (es) | 1997-06-05 |
| AU4067795A (en) | 1996-07-04 |
| MA23746A1 (fr) | 1996-07-01 |
| CZ344795A3 (en) | 1996-09-11 |
| BR9505995A (pt) | 1997-12-23 |
| HUT74672A (en) | 1997-01-28 |
| HU9503783D0 (en) | 1996-04-29 |
| FI972696A7 (fi) | 1997-06-23 |
| FI972696A0 (fi) | 1997-06-23 |
| IL116399A0 (en) | 1996-03-31 |
| MX9704683A (es) | 1997-09-30 |
| LV11325B (en) | 1997-02-20 |
| PL311997A1 (en) | 1996-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
| ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
| NO944377D0 (no) | Kjölemiddelblandinger | |
| ES2106965T3 (es) | Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa. | |
| FI974241L (fi) | BPM-15 -koostumukset | |
| BG99177A (bg) | Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза | |
| DZ1835A1 (fr) | Nouvelles formulations. | |
| DE69840603D1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
| IT1285770B1 (it) | Composti corticoidei | |
| ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
| DE19581542T1 (de) | Gaserzeugende Zusammensetzung | |
| DE69402623D1 (de) | Rostschutzzusammensetzung | |
| NO964238D0 (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| DE69625230D1 (de) | Thrombininhibitoren | |
| IT1278016B1 (it) | Composizione stagionabili di amine. | |
| DK0977871T3 (da) | Neurotrypsin | |
| TR199900430T2 (xx) | �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar. | |
| DE69603228D1 (de) | Aluminoxanate-Zusammensetzungen | |
| MA23731A1 (fr) | Compositions detegentes | |
| NO960636L (no) | Kraft-forsterker | |
| ATE213236T1 (de) | Substituierte benzyloxyimino-verbindungen | |
| ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge | |
| YU48719B (sh) | Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida |